(10/04/2024)vs ΔΗΜΟΣ ΦΙΛΑΔΕΛΦΕΙΑΣ ΧΑΛΚΗΔΟΝΑΣ | 29 | 15 | 4 / 850% | 1 / 1100% | 3 / 1225% | 4 / 1330.8% | | 3 | 2 | 1 | 3 | 0 | 2 | 0 | 2 | 5 |
(03/04/2024)vs ΔΗΜΟΣ ΦΙΛΑΔΕΛΦΕΙΑΣ ΧΑΛΚΗΔΟΝΑΣ | 27 | 8 | 2 / 366.7% | 3 / 742.9% | 0 / 90% | 3 / 1618.8% | | 1 | 3 | 0 | 3 | 1 | 2 | 0 | 2 | -2 |
(11/03/2024)vs SYNERGY TITANS | 40 | 13 | 2 / 450% | 4 / 1330.8% | 1 / 119.1% | 5 / 2420.8% | | 3 | 4 | 1 | 5 | 1 | 1 | 0 | 3 | -4 |
(06/03/2024)vs NETCOMPANY INTRASOFT | 40 | 11 | 0 / 20% | 1 / 714.3% | 3 / 1030% | 4 / 1723.5% | | 1 | 3 | 2 | 5 | 3 | 1 | 0 | 0 | 5 |
(14/02/2024)vs NICKAN | 34 | 7 | 3 / 650% | 2 / 540% | 0 / 30% | 2 / 825% | | 1 | 5 | 1 | 6 | 1 | 0 | 0 | 1 | 4 |
(07/02/2024)vs ΙΑΤΡΙΚΟ ΚΕΝΤΡΟ BC | 31 | 13 | 1 / 250% | 3 / 475% | 2 / 1020% | 5 / 1435.7% | | 2 | 3 | 1 | 4 | 0 | 1 | 0 | 2 | 6 |
(31/01/2024)vs Σ.Ε.Ε.Τ.Τ. | 17 | 0 | 0 / 00% | 0 / 10% | 0 / 20% | 0 / 30% | | 1 | 3 | 0 | 3 | 2 | 0 | 0 | 2 | 0 |
(23/01/2024)vs UNISYSTEMS | 33 | 11 | 2 / 450% | 3 / 650% | 1 / 714.3% | 4 / 1330.8% | | 3 | 1 | 0 | 1 | 2 | 0 | 0 | 2 | 1 |
(17/01/2024)vs PHARMACIA | 13 | 3 | 0 / 00% | 0 / 20% | 1 / 333.3% | 1 / 520% | | 1 | 0 | 0 | 0 | 3 | 1 | 0 | 0 | 3 |
(12/01/2024)vs Σ.Ε.ΤΑΠ. | 22 | 14 | 1 / 250% | 2 / 366.7% | 3 / 837.5% | 5 / 1145.5% | | 0 | 1 | 0 | 1 | 1 | 0 | 0 | 0 | 9 |
(20/12/2023)vs Σ.Ε.ΤΑΠ. | 31 | 6 | 0 / 00% | 0 / 30% | 2 / 825% | 2 / 1118.2% | | 1 | 5 | 1 | 6 | 0 | 1 | 0 | 1 | 3 |
(13/12/2023)vs NETCOMPANY INTRASOFT | 34 | 7 | 2 / 2100% | 1 / 425% | 1 / 714.3% | 2 / 1118.2% | | 1 | 1 | 1 | 2 | 2 | 2 | 0 | 1 | 3 |
(29/11/2023)vs ΔΙΚΗΓΟΡΙΚΟΣ ΣΥΛΛΟΓΟΣ ΠΕΙΡΑΙΑ | 11 | 4 | 0 / 00% | 2 / 366.7% | 0 / 10% | 2 / 450% | | 0 | 0 | 0 | 0 | 1 | 1 | 0 | 0 | 4 |
(15/11/2023)vs ΙΑΤΡΙΚΟ ΚΕΝΤΡΟ BC | 32 | 12 | 4 / 757.1% | 1 / 520% | 2 / 728.6% | 3 / 1225% | | 3 | 6 | 1 | 7 | 3 | 2 | 0 | 1 | 11 |
(08/11/2023)vs Σ.Ε.Ε.Τ.Τ. | 17 | 5 | 1 / 250% | 2 / 366.7% | 0 / 30% | 2 / 633.3% | | 2 | 2 | 0 | 2 | 0 | 0 | 0 | 1 | 1 |
(01/11/2023)vs UNISYSTEMS | 09 | 0 | 0 / 00% | 0 / 20% | 0 / 10% | 0 / 30% | | 0 | 1 | 1 | 2 | 0 | 1 | 0 | 0 | 0 |
(24/10/2023)vs PHARMACIA | 16 | 8 | 1 / 250% | 2 / 2100% | 1 / 333.3% | 3 / 560% | | 0 | 5 | 0 | 5 | 1 | 2 | 0 | 0 | 13 |
ΣΥΝΟΛΙΚΑ |
436 |
137 |
23 / 4452.3% |
27 / 7138.0% |
20 / 10519.0% |
47 / 17626.7% |
|
23 |
45 |
10 |
55 |
21 |
17 |
0 |
18 |
62 |
ΜΕΣΟΙ ΟΡΟΙ |
25.6 |
8.1 |
1.4 / 2.652.3% |
1.6 / 4.238.0% |
1.2 / 6.219.0% |
2.8 / 10.426.7% |
|
1.4 |
2.6 |
0.6 |
3.2 |
1.2 |
1 |
0 |
1.1 |
3.6 |